These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 19895620)

  • 1. Impact of substance use on the physical health of patients with bipolar disorder.
    Garcia-Portilla MP; Saiz PA; Benabarre A; Florez G; Bascaran MT; Díaz EM; Bousoño M; Bobes J
    Acta Psychiatr Scand; 2010 Jun; 121(6):437-45. PubMed ID: 19895620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk in patients with bipolar disorder.
    Garcia-Portilla MP; Saiz PA; Bascaran MT; Martínez A S; Benabarre A; Sierra P; Torres P; Montes JM; Bousoño M; Bobes J;
    J Affect Disord; 2009 Jun; 115(3):302-8. PubMed ID: 18954911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-specific prevalence of metabolic syndrome in Italian patients with bipolar disorder.
    Salvi V; D'Ambrosio V; Rosso G; Bogetto F; Maina G
    Psychiatry Clin Neurosci; 2011 Feb; 65(1):47-54. PubMed ID: 21265935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism, lifestyle and bipolar affective disorder.
    Morriss R; Mohammed FA
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):94-101. PubMed ID: 16280342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loneliness and the metabolic syndrome in a population-based sample of middle-aged and older adults.
    Whisman MA
    Health Psychol; 2010 Sep; 29(5):550-4. PubMed ID: 20836610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different profile of substance abuse in relation to predominant polarity in bipolar disorder: The Vitoria long-term follow-up study.
    González-Pinto A; Alberich S; Barbeito S; Alonso M; Vieta E; Martínez-Arán A; Saenz M; López P
    J Affect Disord; 2010 Aug; 124(3):250-5. PubMed ID: 19959240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bipolar disorder preceded by substance abuse: a different phenotype with not so poor outcome?
    Pacchiarotti I; Di Marzo S; Colom F; Sánchez-Moreno J; Vieta E
    World J Biol Psychiatry; 2009; 10(3):209-16. PubMed ID: 17886170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
    Bolton JM; Robinson J; Sareen J
    J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome in bipolar disorder: a cross-sectional assessment of a Health Management Organization database.
    Sicras A; Rejas J; Navarro R; Serrat J; Blanca M
    Bipolar Disord; 2008 Jul; 10(5):607-16. PubMed ID: 18657245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in prevalence and patterns of substance use in schizophrenia and bipolar disorder.
    Ringen PA; Lagerberg TV; Birkenaes AB; Engn J; Faerden A; Jónsdottir H; Nesvåg R; Friis S; Opjordsmoen S; Larsen F; Melle I; Andreassen OA
    Psychol Med; 2008 Sep; 38(9):1241-9. PubMed ID: 18070373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic syndrome and associated risk factors in an urban industrial male population in South India.
    Kaur P; Radhakrishnan E; Rao SR; Sankarasubbaiyan S; Rao TV; Gupte MD
    J Assoc Physicians India; 2010 Jun; 58():363-6, 371. PubMed ID: 21125777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in advancing mental and physical health of patients with serious mental illness.
    Dursun S; Dinan TG; Bushe C; Thakore J
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):3-5. PubMed ID: 16280332
    [No Abstract]   [Full Text] [Related]  

  • 14. Differences in traditional and emerging cardiovascular risk factors of subjects discordantly classified by metabolic syndrome definitions of the International Diabetes Federation and the National Cholesterol Education Program.
    Boronat M; Saavedra P; Varillas VF; Wagner AM; López-Plasencia Y; Alberiche MP; Nóvoa FJ
    Nutr Metab Cardiovasc Dis; 2009 Jul; 19(6):417-22. PubMed ID: 18819785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of co-occurring mood and anxiety disorders among substance-abusing youth.
    Lubman DI; Allen NB; Rogers N; Cementon E; Bonomo Y
    J Affect Disord; 2007 Nov; 103(1-3):105-12. PubMed ID: 17291589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic and lifestyle issues and severe mental illness--new connections to well-being?
    J Psychopharmacol; 2005 Nov; 19(6 Suppl):188-22. PubMed ID: 19886294
    [No Abstract]   [Full Text] [Related]  

  • 17. Substance abuse in bipolar disorder.
    Cassidy F; Ahearn EP; Carroll BJ
    Bipolar Disord; 2001 Aug; 3(4):181-8. PubMed ID: 11552957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical comorbidity and health-related quality of life in bipolar disorder across the adult age span.
    Fenn HH; Bauer MS; Altshuler L; Evans DR; Williford WO; Kilbourne AM; Beresford TP; Kirk G; Stedman M; Fiore L;
    J Affect Disord; 2005 May; 86(1):47-60. PubMed ID: 15820270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts.
    Vuksan-Cusa B; Marcinko D; Nad S; Jakovljević M
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):109-12. PubMed ID: 19026707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of vascular risk factors in late onset bipolar disorder.
    Subramaniam H; Dennis MS; Byrne EJ
    Int J Geriatr Psychiatry; 2007 Aug; 22(8):733-7. PubMed ID: 17146839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.